Effectiveness of Paxlovid, an Oral Antiviral Drug, Against the Omicron BA.5 Variant in Korea: Severe Progression and Death Between July and November 2022
Kim et al., Journal of Korean Medical Science, doi:10.3346/jkms.2023.38.e211
https://c19early.org/kim13.html